REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,486,000 | -13.5% | 200,000 | 0.0% | 0.07% | -1.4% |
Q1 2015 | $1,718,000 | +7.6% | 200,000 | +116.6% | 0.07% | +19.7% |
Q2 2014 | $1,596,000 | -38.9% | 92,318 | -37.5% | 0.06% | -54.1% |
Q1 2014 | $2,613,000 | -76.2% | 147,618 | -75.4% | 0.13% | -73.6% |
Q4 2013 | $10,982,000 | -35.6% | 600,418 | -5.7% | 0.50% | -39.9% |
Q3 2013 | $17,056,000 | +29.0% | 636,418 | -11.2% | 0.84% | +7.2% |
Q2 2013 | $13,218,000 | – | 716,418 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
Airain ltd | 13,690 | $13,000 | 0.00% |